Inactive Instrument

Amylin Pharmaceuticals LLC Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

02/12/02	Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	RE
17/12/17	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

02/12/02	Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	RE
17/12/17	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE
16/12/16	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	RE
15/12/15	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	RE
11/12/11	Forest Laboratories, Inc. : Exclusive: Icahn offered to settle with Forest before battle	RE
10/12/10	Exclusive: Icahn offered to settle with Forest before battle	RE
03/12/03	SANOFI : Icahn return on Amylin tops 35 percent	RE
03/12/03	Bristol Myers Squibb Co. : Bristol's patent woes persist despite Amylin buy	RE
30/12/30	SANOFI : AstraZeneca hungry to refill medicine cabinet	RE
30/12/30	SANOFI : Bristol-Myers to buy Amylin for about $5.3 billion	RE
02/12/02	Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	RE
01/12/01	Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	RE
26/12/26	Ardea Biosciences, Inc. : Watson to buy Actavis for at least $5.6 billion	RE

09/12/09	Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin	PU
12/12/12	Amylin Pharmaceuticals, Inc. : The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Corporation	BU
09/12/09	Amylin Pharmaceuticals, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.	PR
07/12/07	Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.	BU
04/12/04	Amylin Pharmaceuticals, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.	PR

16/12/16	GSK annonce le rachat de Human Genome pour $3,0 milliards
03/12/03	Wall Street termine sans grande tendance après les PMI
02/12/02	USA-Les valeurs à suivre à Wall Street
30/12/30	Le laboratoire Bristol-Myers lance une OPA amicale sur Amylin
31/12/31	Sanofi veut élargir son offre sur le marché du diabète

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.61%	-3.43%	+36.07%	+117.61%	1,01900Cr
JOHNSON & JOHNSON	-1.02%	-5.60%	+35.72%	+64.82%	62TCr
ABBVIE INC.	+1.11%	-0.58%	+12.36%	+78.27%	46TCr
MERCK & CO., INC.	+0.34%	-3.01%	+61.79%	+41.79%	36TCr
ROCHE HOLDING AG	-0.95%	-4.05%	+20.54%	+40.33%	33TCr
NOVARTIS AG	-1.46%	-2.89%	+10.57%	+26.54%	27TCr
ASTRAZENECA PLC	-1.35%	-5.43%	-6.17%	+8.82%	24TCr
AMGEN INC.	-1.04%	-2.79%	+35.30%	+54.42%	22TCr
GILEAD SCIENCES, INC.	-1.87%	-4.10%	+28.44%	+97.54%	18TCr
Average	-0.76%	-3.39%	+26.07%	+58.90%	41.08TCr
Weighted average by Cap.	-0.60%	-3.33%	+29.07%	+71.15%

Employees

Sector